Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$23.4

Avg closing price
Price range

8 Ken Griffin Avenue Therapeutics Trades

The first Avenue Therapeutics trade was made in Q3 2021. Since then Ken Griffin bought shares three more times and sold shares on four occasions. The investor sold all their shares in Q1 2024 and doesn't own any shares in Avenue Therapeutics anymore.

Avg closing price
Price range
Sold -1.18 Thousand shares Q1 2024
Avg closing price $11.85
Price range $9.00 - $25.67
New holding (+1.18 Thousand shares) Q4 2023
Avg closing price $23.40
Price range $10.20 - $52.54
Sold -478 shares Q4 2022
Avg closing price $181.00
Price range $86.25 - $1,087.50
New holding (+478 shares) Q3 2022
Avg closing price $306.60
Price range $4.50 - $756.00
Sold -104 shares Q2 2022
Avg closing price $385.18
Price range $247.50 - $628.99
Increased shares by 395.2% (+83 shares) Q1 2022
Avg closing price $747.49
Price range $241.99 - $1,080.56
Sold 8.7% shares (-2 shares) Q4 2021
Avg closing price $1,445.92
Price range $991.13 - $2,002.28
New holding (+24 shares) Q3 2021
Avg closing price $2,066.31
Price range $1,665.00 - $2,981.25

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!